Pharma minutes

Friday, 16 February 2018

IPCA lab walk in interview on 25th Feb 2018

Labels: Job

Creador to invest Rs 118 crore in Corona Remedies

Private equity firm Creador plans to invest Rs 118 crore in pharmaceutical firm Corona Remedies. Cydista Ltd, an affiliate of Creador III ...
Drug overcharging case: Supreme Court directs Cipla to pay Rs 175.07 crore

Cipla has been asked by the Supreme Court to deposit Rs 175.07 crore with regard to cases pertaining to overcharging of certain drugs, t...
Roche, Biocon clash accusing contempt of court

The ongoing battle between Swiss drug maker Roche and Bangalore-based biotech major Biocon over breast cancer drug trastuzumab has taken ...
Valeant Pharma gets US FDA CRL for latanoprostene bunod ophthalmic solution 0.024% NDA

Valeant Pharmaceuticals International, Inc. has received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) re...
Novartis, Teva generics suspended by EMA over issues with Indian CRO

Failings at an Indian CRO have tripped up Novartis ($NVS) and Teva ($TEVA) as the European Medicines Agency (EMA) today said it would susp...

Simple theme. Powered by Blogger.